Contribution of plasma lipid disturbances to vascular endothelial function in patients with slow coronary flow

Alpay Turan Sezgin1, Irfan Barutcu, Nurzen Sezgin

  • 1Department of Cardiology, Baskent University, Practice and Research Hospital, Adana, Turkey.

Angiology
|January 20, 2007
PubMed

Insights

Plasma lipid disturbances, particularly low high-density lipoprotein cholesterol (HDL-C) and high triglycerides (TG), are linked to slow coronary flow (SCF). This study found reduced flow-mediated dilatation (FMD) in SCF patients associated with these lipid abnormalities.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Lipid Metabolism

Background:

  • Slow coronary flow (SCF) is a microcirculatory abnormality, but its underlying mechanisms remain unclear.
  • Previous research suggests a link between microcirculatory dysfunction and lipid disturbances.

Purpose of the Study:

  • To investigate the role of plasma lipid disturbances in the pathogenesis of slow coronary flow (SCF).
  • To determine the association between lipid profiles and endothelial function in patients with SCF.

Main Methods:

  • Cross-sectional study comparing 40 SCF patients with 37 healthy controls.
  • Measurement of plasma lipid concentrations (total cholesterol, LDL-C, HDL-C, TG).
  • Assessment of brachial artery flow-mediated dilatation (FMD) and nitroglycerin-induced dilatation.

Main Results:

  • SCF patients exhibited lower HDL-C and higher TG levels compared to controls.
  • Flow-mediated dilatation (FMD) was significantly reduced in SCF patients.
  • Plasma HDL-C levels were independently associated with FMD in SCF patients.

Conclusions:

  • Plasma lipid disturbances, specifically low HDL-C and high TG, are associated with impaired endothelial function in SCF.
  • These findings highlight the potential role of lipid management in addressing slow coronary flow.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...